Ceftin (cefuroxime) for Lyme disease

July 1997

    Glaxo is now promoting Ceftin (cefuroxime) for Lyme disease. It's the first antibiotic to be officially approved for this use.

    It's for patients with symptoms of EARLY Lyme disease...usually a rash and flu-like symptoms. These symptoms usually show up BEFORE antibodies are detectable on blood tests.

    Prompt treatment usually prevents long-term complications.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote